Hackensack Meridian Health
Hackensack Meridian Health operates a comprehensive and integrated healthcare network in New Jersey, dedicated to providing a complete range of medical services and innovative care. The organization focuses on enhancing preventative care, managing chronic conditions, and maintaining financial viability in a value-based environment. Their offerings include ambulatory care centers, surgery centers, home health services, long-term care, assisted living, ambulance services, air medical transportation, rehabilitation, urgent care, and wellness programs. With a commitment to family and patient-centered care, Hackensack Meridian Health emphasizes world-class education and research, aiming to better serve the health needs of communities across New Jersey.
FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™ technology is a revolutionary platform designed to build tissue using cells, proteins, and nothing else. Through partnerships with top life science companies, our technology has been validated to produce the highest quality tissue in a variety of applications. We deliver human tissue that is indistinguishable from the real thing by integrating breakthrough innovations in 3D printing, computational and synthetic biology, AI, and advanced materials science. Our living tissue will offer therapies to countless patients who deserve better treatment options. FluidForm Bio™was founded in 2018 on the belief that the world needs transformational technologies led by creative and passionate experts that help people lead better lives. Headquartered in Waltham, MA.
Private Equity Round in 2021
Med-Metrix provides Performance Management and Revenue Cycle solutions to the healthcare industry. Designed specifically to improve clients' margins and productivity, their offerings leverage their proprietary FLOWtechnology platform ® of graphic-rich reporting and automated workflow coupled with advisory and outsource services as needed.
EpiBone is a pioneering regenerative medicine company at the forefront of bone and cartilage repair. Leveraging the power of stem cells, biomimicry, and 3D fabrication, they are developing a pipeline of innovative products with enormous potential to revolutionize orthopedic repair. Their lead product, a living, anatomically precise 3D bone graft, completed its Phase I/IIa clinical trial in August 2023. The rest of their pipeline focuses on cartilage repair, and includes an allogeneic osteochondral plug, whose IND was approved in July 2023. Their cartilage portfolio also includes an injectable cartilage filler that was partly funded by the Department of Defense.
Pillo Health provides HIPAA compliant tools for caregivers and health organizations to deliver better care to loved ones and patients living at home. The company's care delivery platform is centered on an intelligent healthcare assistant called Pillo. In addition to managing medications, Pillo can provide patients at home with health and wellness information, can proactively deliver digital care plans into the home, and can connect the home to care teams via smart notifications and video calling. The company also offers an SDK for partner organizations to create their own unique skills for Pillo by leveraging the company's proprietary in home voice first device.
COTA was founded in 2011 by doctors, engineers, and data scientists to create clarity from fragmented and often-inaccessible real world data. By using proprietary technology, advanced analytics and deep expertise to organize complex data, COTA provides a comprehensive picture of cancer that can be used to advance care and research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.